IGFBP7 and acute kidney injury: Our study, in which most (92%) CS-AKI cases were mild (stage 1), contrary to several previous studies [9], discourages to extend the indication for TIMP2 IGFBP7 to the detection of mild CS-AKI developing within the 48 postoperative hours.